American Journal of Kidney Diseases
Volume 50, Issue 3 , Pages 396-403 , September 2007

Long-Term Risk of Cancer in Membranous Nephropathy Patients

  • Rune Bjørneklett, MD

      Affiliations

    • The Norwegian Kidney Biopsy Registry, Haukeland University Hospital, Bergen, Norway
    • Renal Research Group, Institute of Medicine, University of Bergen, Bergen, Norway
    • ,
  • Bjørn Egil Vikse, MD, PhD

      Affiliations

    • The Norwegian Kidney Biopsy Registry, Haukeland University Hospital, Bergen, Norway
    • Renal Research Group, Institute of Medicine, University of Bergen, Bergen, Norway
    • ,
  • Einar Svarstad, MD, PhD

      Affiliations

    • The Norwegian Kidney Biopsy Registry, Haukeland University Hospital, Bergen, Norway
    • Renal Research Group, Institute of Medicine, University of Bergen, Bergen, Norway
    • ,
  • Knut Aasarød, MD, PhD

      Affiliations

    • Department of Medicine, Division of Nephrology, St Olavs University Hospital, Trondheim, Norway
    • ,
  • Leif Bostad, MD

      Affiliations

    • The Norwegian Kidney Biopsy Registry, Haukeland University Hospital, Bergen, Norway
    • Gades Institute, University of Bergen, Bergen, Norway
    • ,
  • Frøydis Langmark, MD, PhD

      Affiliations

    • The Cancer Registry of Norway, Oslo, Norway.
    • ,
  • Bjarne M. Iversen, MD, PhD

      Affiliations

    • The Norwegian Kidney Biopsy Registry, Haukeland University Hospital, Bergen, Norway
    • Renal Research Group, Institute of Medicine, University of Bergen, Bergen, Norway
    • Corresponding Author InformationAddress correspondence to Bjarne M. Iversen, MD, PhD, Department of Medicine, Haukeland University Hospital, 5021 Bergen, Norway.

Received 30 January 2007 ,Accepted 13 June 2007.

References 

  1. Wasserstein AG. Membranous glomerulonephritis. J Am Soc Nephrol. 1997;8:664–674
  2. Galloway J. Remarks on Hodgkin’s disease. Br Med J. 1922;2:1201
  3. Wakashin M, Wakashin Y, Iesato K, et al. Association of gastric cancer and nephrotic syndrome (An immunologic study in three patients). Gastroenterology. 1980;78:749–756
  4. Costanza ME, Pinn V, Schwartz RS, Nathanson L. Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome. N Engl J Med. 1973;289:520–522
  5. Ohtani H, Wakui H, Komatsuda A, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant. 2004;19:574–579
  6. Lewis MG, Loughridge LW, Phillips TM. Immunological studies in nephrotic syndrome associated with extrarenal malignant disease. Lancet. 1971;2:134–135
  7. Touchard G, Preud’homme JL, Aucouturier P, et al. Nephrotic syndrome associated with chronic lymphocytic leukemia: An immunological and pathological study. Clin Nephrol. 1989;31:107–116
  8. Ronco PM. Paraneoplastic glomerulopathies: New insights into an old entity. Kidney Int. 1999;56:355–377
  9. Lee JC, Yamauchi H, Hopper J. The association of cancer and the nephrotic syndrome. Ann Intern Med. 1966;64:41–51
  10. Cahen R, Francois B, Trolliet P, Gilly J, Parchoux B. Aetiology of membranous glomerulonephritis: A prospective study of 82 adult patients. Nephrol Dial Transplant. 1989;4:172–180
  11. Birkeland SA, Storm HH. Glomerulonephritis and malignancy: A population-based analysis. Kidney Int. 2003;63:716–721
  12. Eagen JW. Glomerulopathies of neoplasia. Kidney Int. 1977;11:297–303
  13. Burstein DM, Korbet SM, Schwartz MM. Membranous glomerulonephritis and malignancy. Am J Kidney Dis. 1993;22:5–10
  14. Lefaucheur C, Stengel B, Nochy D, et al. Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. Kidney Int. 2006;70:1510–1517
  15. Brueggemeyer CD, Ramirez G. Membranous nephropathy: A concern for malignancy. Am J Kidney Dis. 1987;9:23–26
  16. Zech P, Colon S, Pointet P, Deteix P, Labeeuw M, Leitienne P. The nephrotic syndrome in adults aged over 60: Etiology, evolution and treatment of 76 cases. Clin Nephrol. 1982;17:232–236
  17. Glassock RJ. Secondary membranous glomerulonephritis. Nephrol Dial Transplant. 1992;7(suppl 1):S64–S71
  18. Rihova Z, Honsova E, Merta M, et al. Secondary membranous nephropathy—One center experience. Ren Fail. 2005;27:397–402
  19. Luyckx C, Van Damme B, Vanrenterghem Y, Maes B. Carcinoid tumor and membranous glomerulonephritis: Coincidence or malignancy-associated glomerulonephritis?. Clin Nephrol. 2002;57:80–84
  20. Ng SB, Tan PH, Chuah KL, Cheng C, Tan J. A case of juxtaglomerular cell tumor associated with membranous glomerulonephritis. Ann Diagn Pathol. 2003;7:314–320
  21. Butty H, Asfoura J, Cortese F, Doyle M, Rutecki G. Chronic lymphocytic leukemia-associated membranous glomerulopathy: Remission with fludarabine. Am J Kidney Dis. 1999;33:E8
  22. Yamauchi H, Linsey MS, Biava CG, Hopper J. Cure of membranous nephropathy after resection of carcinoma. Arch Intern Med. 1985;145:2061–2063
  23. Gomez Carrera L, Prados C, Alvarez-Sala R, Garcia Rio T, Villamor J, Martinez-Ara J. Membranous glomerulonephritis and melanoma: A causal correlation?. J Natl Cancer Inst. 1994;86:64–65
  24. Togawa A, Yamamoto T, Suzuki H, et al. Membranous glomerulonephritis associated with renal cell carcinoma: Failure to detect a nephritogenic tumor antigen. Nephron. 2002;90:219–221
  25. Yahata N, Kawanishi Y, Okabe S, et al. Membranous glomerulonephritis with nephrotic syndrome associated with chronic lymphocytic leukemia. Am J Nephrol. 2000;20:402–407
  26. Tourneur F, Bouvier R, Langue J, et al. Membranous nephropathy and orbital malignant tumor. Pediatr Nephrol. 2000;14:53–55
  27. Ashman N, Steele JP, Sheaff M, Rudd RM, Onwubalili J. Membranous nephropathy resolving with treatment of bronchial carcinoid tumor. Am J Kidney Dis. 2000;36:E15
  28. Matsuura H, Sakurai M, Arima K. Nephrotic syndrome due to membranous nephropathy associated with metastatic prostate cancer: Rapid remission after initial endocrine therapy. Nephron. 2000;84:75–78
  29. Alpers CE, Cotran RS. Neoplasia and glomerular injury. Kidney Int. 1986;30:465–473
  30. Harvei S, Tretli S, Langmark F. Quality of prostate cancer data in the Cancer Registry of Norway. Eur J Cancer. 1996;32A:104–110
  31. Tingulstad S, Halvorsen T, Norstein J, Hagen B, Skjeldestad FE. Completeness and accuracy of registration of ovarian cancer in the Cancer Registry of Norway. Int J Cancer. 2002;98:907–911
  32. Keur I, Krediet RT, Arisz L. Glomerulopathy as a paraneoplastic phenomenon. Neth J Med. 1989;34:270–284
  33. Row PG, Cameron JS, Turner DR, et al. Membranous nephropathy (Long-term follow-up and association with neoplasia). Q J Med. 1975;44:207–239
  34. Adami J, Gabel H, Lindelof B, et al. Cancer risk following organ transplantation: A nationwide cohort study in Sweden. Br J Cancer. 2003;89:1221–1227
  35. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardiorenal syndrome: ‘Guyton revisited.’. Eur Heart J. 2005;26:11–17

 Originally published online as doi: 10.1053/j.ajkd.2007.06.003 on August 2, 2007.

PII: S0272-6386(07)00928-6

doi: 10.1053/j.ajkd.2007.06.003

American Journal of Kidney Diseases
Volume 50, Issue 3 , Pages 396-403 , September 2007

Article Tools

* Image Usage & Resolution